![]() |
![]() |
|
Alström Syndrome International
For Families
Contact Us
|
Introduction to the ProfessionalWelcome to the world of Alstrom Syndrome! As you already know, Alstrom syndrome is a very complex condition with multiple challenges for management and monitoring. We often receive inquiries from professionals who are working with an individual with Alstrom Syndrome looking for information. Unfortunately, because of the rarity of Alstrom, medical information is scarce and we are only beginning to bring together the knowledge for physicians, educators, and other specialists who work with individuals with Alstrom Syndrome. Since the identification of the gene causing Alstrom Syndrome (ALMS1) in 2000, there is now more interest and an increasing body of information. If you are interested in more detailed medical information, see the comprehensive summary at European Journal Human Genetics (Practical Genetics) Review Article . If you have a patient with Alstrom Syndrome and would like to participate in research, we maintain an ongoing registry and database of patients in more than 45 different countries. Please contact me at jan.marshall@jax.org We are always eager to obtain clinical information about any patient with Alstrom syndrome. If you wish to contribute to this effort, please see the documents below:
Jan D. Marshall International Scientific Conference Padua 2008 Abstracts
|
Important Urgent informationFor patients with Alström Syndrome admitted to the hospital or outpatient facilities, even if for routine minor surgery, it is vitally important that medical and nursing staff is aware that hypoxia (low blood oxygen levels) can occur very rapidly in patients with Alström Syndrome. In some patients, this has lead to life threatening heart/lung problems because of the reduced reserve capacity of the cardio respiratory system. Please use all precautions for monitoring oxygen saturation. |
The Jackson Laboratory, Bar Harbor ME USA
Genetic evaluation on a research basis:
contact: jan.marshall@jax.org
Centro Genetica Clinica, Porto, Portugal
Sequencing of Selected exons (exon 16, 10, and part of exon 8):
contact: molecular@cgc.pt
AsperBiotech, Toru, Estonia
Microarray screening for all known ALMS1 and BBS mutations
www.asperbiotech.com
| Home - General Information - Alstr öm Syndrome International For Families - For Professionals |
Last Modified: February 21, 2010